Navigating regulatory and policy challenges for AI enabled combination devices.
PMID : 39669903 ·
S, n, i, g, d, h, a, , S, a, n, t, r, a, ;, , P, r, e, e, t, , K, u, k, r, e, j, a, ;, , K, i, n, s, h, u, k, , S, a, x, e, n, a, ;, , S, a, n, y, a, m, , G, a, n, d, h, i, ;, , O, m, , V, , S, i, n, g, h
Publicité
Résumé
In recent years, the Artificial Intelligence (AI) has enabled conventional Combination Devices (CDs) to innovate in healthcare merging with technology sectors. However, the challenges like reliance on predicate devices in US Food and Drug Administration (FDA's 510(k) pathway, especially for perpetually updating AI are stressed. Though the European Union (EU's new Medical Device Regulations address software and AI, fitting adaptive algorithms into conformity assessments remains difficult. The urg
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.